Company Filing History:
Years Active: 1994-1998
Title: The Innovations of Daniel Joseph Doyon
Introduction
Daniel Joseph Doyon is an accomplished inventor based in Florida, NY (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of controlled release compositions. With a total of 2 patents, Doyon has demonstrated his expertise and commitment to innovation.
Latest Patents
Doyon's latest patents include a controlled release carbonic anhydrase inhibitor containing a pharmaceutical composition in oral dosage unit form. This composition comprises a hard or soft shell capsule filled with active spherical granules that contain a therapeutically effective amount of at least one carbonic anhydrase inhibitor. Additionally, it includes a pharmaceutically acceptable solid diluent that forms a diffusable matrix for the active medicament, along with optional excipients. Another notable patent is for controlled release pharmaceutical compositions from spherical granules, which involves a tablet containing active spherical granules and compressible spherical granules. This innovative approach enhances the delivery and effectiveness of the active medicament.
Career Highlights
Doyon is currently associated with American Cyanamid Company, where he continues to work on groundbreaking pharmaceutical innovations. His career reflects a dedication to improving therapeutic options through scientific research and development.
Collaborations
Throughout his career, Doyon has collaborated with notable colleagues, including Wendy Ann Preston and Madurai G Ganesan. These partnerships have contributed to the advancement of his research and the successful development of his patents.
Conclusion
Daniel Joseph Doyon is a prominent figure in the pharmaceutical industry, known for his innovative patents and contributions to controlled release compositions. His work continues to impact the field positively, showcasing the importance of research and collaboration in driving advancements in medicine.